STOCK TITAN

Viking Therapeutics, Inc (VKTX) Revenue by Year

VKTX

Viking Therapeutics, Inc generated $0 in revenue in fiscal year 2025. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Viking Therapeutics, Inc has filed alongside them.

FY2025 annual
Revenue $0
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VKTX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Revenue$0$0$0$0$0$0$0$0$0$0$0$0

VKTX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$0$0N/A$0$0$0N/A$0$0$0N/A$0

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Viking Therapeutics, Inc financials

Frequently Asked Questions

What was Viking Therapeutics, Inc's revenue in fiscal year 2025?

Viking Therapeutics, Inc generated $0 in revenue in fiscal year 2025.

How has Viking Therapeutics, Inc's revenue changed over the years?

Across the 12 fiscal years this page covers, Viking Therapeutics, Inc (VKTX) revenue went from $0 in fiscal year 2014 to $0 in fiscal year 2025.

What was Viking Therapeutics, Inc's revenue in the most recent quarter?

Viking Therapeutics, Inc (VKTX) reported $0 in revenue in Q2 2026.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Viking Therapeutics, Inc (VKTX) reported on that line in every period on record.